Contact Us
Quotes
News
NAV
Market Watch
24 Oct EOD
SENSEX
NIFTY
GOLD
SILVER
CRUDE OIL
Market Info
Equity
Derivatives
Commodities
Mutual Fund
IPO
Other Markets
DAILY MARKET TRACKER
MARKET ANALYSIS
NEWS
CORPORATE INFO
CORPORATE ACTION
DERIVATIVES
FUTURES
OPTIONS
CURRENCY
GET QUOTES
NATIONAL SPOT EXCHANGE
FUND PROFILE
TOP 10 HOLDINGS
FUND RANKING CALCULATOR
EXPAND TICKER
You are here : Corporate Information |
Company News Details
Your Result on : Corporate Information | Company News Details
Welcure Drugs & Pharmaceuticals Ltd
Back
Welcure Drugs & Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Sep 02,2025 Hrs IST
Intimation of appointment of Statutory Auditor under Regulation 30 of SEBI(LODR) Regulation 2015
Detailed Quotes
MF Holdings
Company News
Profit and Loss
Quarterly Results
Share Holding Pattern
Deliverable Volumes
Historical Prices
Board of Directors
Director's Report
Peer Comparison
Score Board
Name Change
Financial Ratios
Company Background
Company Snapshot
Balance Sheet
Site Map
|
Disclaimer
|
Circular Reports
|
Research Reports
|
About Us
|
Feedback
|
Careers
|
Contact Us
Useful Links
NSE
BSE
SEBI
CDSL
NSDL
RBI
FMC
AMFI
Stock Watch
Derivatives on NSE
MOF
NISM
Stock :
Stock Price Quotes
|
Stock Market India
|
Stock Market Global
|
Corporate Announcement
Market News :
Corporate News
|
Market Commentary
|
Corporate Results
|
Economy News
|
Other Markets
|
Hot Pursuit
|
Futures Market
Share Market Updates :
BSE Top Gainers - Sensex
|
NSE Top Gainers - Nifty
|
BSE Top Losers - Sensex
|
NSE Top Losers - Nifty
|
BSE Most Active Scrip by Volume - Sensex
|
NSE Most Active Scrip by Volume - Nifty
|
BSE Most Active Scrip by Value - Sensex
|
NSE Most Active Scrip by Value - Nifty
|
Advances and Declinces
Derivatives :
Get Quotes
|
Daily Settlement Prices
|
Put-Call Ratio
|
Cost Of Carry
Global Indicator :
Stock Market Global
|
Currency
|
ADR Prices
|
FII Investments
|
Mutual Fund Investments
Services :
Equity
|
Derivatives
|
Commodities
|
Mutual Fund
|
Portfolio Management Services (PMS)
|
Initial Public Offer (IPO)
Members:
Sebi Regn.No. - BSE : INB010983738 | NSE : INB230983737 | F&O : INF230983737 | NSE Currency: INE230983737 | FMC REGN.MCX : MCX/TCM/CORP/0276 | NCDEX : NCDEX/TCM/CORP/0411
Email ID for redressal of Investor Complaints :
investorgrievances@manumangal.com
2012 © MANUBHAI MANGALDAS SECURITIES PVT. LTD All rights reserved Designed, developed & powered by
C-MOTS Infotech
(ISO 9001:2008 certified)
BSE
NSE